Earli, Inc.
Developing genetic constructs for early cancer detection and treatment
a16z — Backed by a16z H-1B sponsor history — This employer has had H-1B petitions approved by USCIS in the last five fiscal years, per the USCIS H-1B Employer Data Hub. The approval belongs to the employer and is not a commitment to sponsor this role.Company facts
- Founded
- 2018
- Employees
- 38
- Headquarters
- United States
- Type
- Private
- Funding
- Series A · $20M · 2025
Open positions
1 job
Senior Scientist, Bio AI
Open 148d 8 months ago2 viewsSeniorNo extra questions
United States
Redwood City, CAEarli tackles the #1 problem in the $100B cancer drug market: systemic toxicity. On-target/off-tumor effects force suboptimal dosing, reduced efficacy and sidelining some of the most potent drug classes such as…
AI Bioinformatics Cloud Data Science Fine Tuning +5 skills